ArteraAI Prostate Test
Commercial- Indications
- Prostate cancer
Company intelligence / Profile preview
ArteraAI
Los Altos, California, United Statesartera.ai ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The ArteraAI Prostate Test is the first AI-enabled diagnostic that can both predict therapeutic benefit from hormone therapy and prognosticate long-term outcomes for patients with localized prostate cancer. It is validated by multiple Phase 3 clinical trials, included in NCCN Clinical Practice Guidelines, and available commercially in the US, UK, and Australia. The test leverages digital pathology images and clinical data to provide individualized risk stratification within days of sample receipt. Recent registry studies are underway to assess real-world impact on patient care.
- Therapeutic areas
- Oncology
- Modalities
- Device (diagnostic test)Artificial intelligence platform (MMAI - multimodal artificial intelligence)
- Industry
- Pathology
02
Drug pipeline
1 asset03
Partnerships
PathNetCorePlus
Beyond the preview
Go deeper on ArteraAI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ArteraAI.